Legacy Financial Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.33M | Sell |
2,981
-105
| -3% | -$46.7K | 0.21% | 79 |
|
|
2025
Q1 | $1.5M | Buy |
3,086
+534
| +21% | +$259K | 0.25% | 69 |
|
|
2024
Q4 | $1.03M | Buy |
2,552
+104
| +4% | +$41.9K | 0.17% | 104 |
|
|
2024
Q3 | $1.14M | Buy |
2,448
+25
| +1% | +$11.6K | 0.19% | 89 |
|
|
2024
Q2 | $1.14M | Buy |
2,423
+117
| +5% | +$54.8K | 0.2% | 79 |
|
|
2024
Q1 | $964K | Buy |
2,306
+147
| +7% | +$61.4K | 0.17% | 96 |
|
|
2023
Q4 | $878K | Buy |
2,159
+232
| +12% | +$94.4K | 0.17% | 91 |
|
|
2023
Q3 | $670K | Buy |
1,927
+376
| +24% | +$131K | 0.13% | 100 |
|
|
2023
Q2 | $546K | Buy |
1,551
+163
| +12% | +$57.4K | 0.1% | 127 |
|
|
2023
Q1 | $437K | Buy |
1,388
+92
| +7% | +$29K | 0.09% | 141 |
|
|
2022
Q4 | $374K | Buy |
1,296
+26
| +2% | +$7.51K | 0.08% | 146 |
|
|
2022
Q3 | $368K | Buy |
1,270
+116
| +10% | +$33.6K | 0.09% | 133 |
|
|
2022
Q2 | $325K | Buy |
1,154
+170
| +17% | +$47.9K | 0.08% | 139 |
|
|
2022
Q1 | $257K | Buy |
+984
| New | +$257K | 0.06% | 193 |
|
|
2019
Q2 | – | Sell |
-149
| Closed | -$27K | – | 887 |
|
|
2019
Q1 | $27K | Buy |
149
+23
| +18% | +$4.17K | 0.01% | 402 |
|
|
2018
Q4 | $21K | Buy |
126
+116
| +1,160% | +$19.3K | 0.01% | 406 |
|
|
2018
Q3 | $1K | Hold |
10
| – | – | ﹤0.01% | 864 |
|
|
2018
Q2 | $2K | Sell |
10
-43
| -81% | -$8.6K | ﹤0.01% | 840 |
|
|
2018
Q1 | $8K | Buy |
53
+48
| +960% | +$7.25K | ﹤0.01% | 551 |
|
|
2017
Q4 | $0 | Buy |
+5
| New | – | ﹤0.01% | 862 |
|